This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The State University of New York, Health Research, Inc.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2021
Title: Kevin Carter: Innovator in Nanotechnology
Introduction
Kevin Carter is a prominent inventor based in Amherst, NY (US). He has made significant contributions to the field of nanotechnology, particularly in the development of serum-stable nanoparticles and light-triggered release mechanisms. With a total of 2 patents, his work has the potential to revolutionize drug delivery systems.
Latest Patents
Carter's latest patents include "Serum-stable compositions and methods for light-triggered release of materials." This patent describes serum-stable nanoparticles that comprise porphyrin-phospholipid conjugates. These nanoparticles can carry therapeutic and diagnostic agents, enabling drug delivery methods that utilize near-infrared (NIR) light for cargo release. Another notable patent is "Compositions and method for light-triggered release of materials from nanovesicles." This invention focuses on porphyrin-phospholipid nanovesicles (PoP-NVs) that can be loaded with various cargo, with methods for releasing this cargo triggered by NIR light.
Career Highlights
Throughout his career, Kevin Carter has worked with esteemed institutions such as the State University of New York and Health Research, Inc. His innovative research has garnered attention and respect within the scientific community.
Collaborations
Carter has collaborated with notable colleagues, including Jonathan Lovell and Shuai Shao. Their combined expertise has contributed to advancements in the field of nanotechnology.
Conclusion
Kevin Carter's work in nanotechnology, particularly in serum-stable nanoparticles and light-triggered release systems, showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for more effective drug delivery methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile